Metagenomi Therapeutics (MGX) Stock Price, Quote, News & History

Comments

Metagenomi Therapeutics Inc (MGX) Stock Price, Quote, News & History

MGXNASDAQ

Trade with Public

$1.46

-0.11-7.01%

At close: Mar 13, 5:00 PM EST

$1.47

0.010.68%

After Hours: Mar 13, 4:44 PM EST

OverviewNews Earnings Analyst Ratings Insider Trades Short Interest Stock Report

Key Statistics

Open

$1.57

$1.46

Volume / Avg.

336.67K / 288.34K

Day Range

$1.46 - $1.62

52 Wk Range

1.23 - 3.95

Market Cap

$55.17M

P/E Ratio

Dividend Yield

Exchange

NASDAQ

RSI

Short Interest

7.06%

Days to Cover

12.09

Recent Metagenomi Therapeutics Inc News

Metagenomi Therapeutics Q4 Earnings Assessment

Benzinga Insights

PRO
Metagenomi Q4 EPS $(0.60) Beats $(0.62) Estimate, Sales $3.911M Miss $6.745M Estimate

Benzinga Newsdesk

PRO
Metagenomi Changes Name To Metagenomi Therapeutics

New name reflects the Company's strategic evolution focused on later-stage preclinical assets leveraging its most advanced, signature gene-editing capabilitiesPre-IND meeting held in 4Q 2025 following MGX-001 preclinical

Benzinga Newsdesk

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Rating and Forecast

4.0

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Key Statistics

Open

$1.57

$1.46

Volume / Avg.

336.67K / 288.34K

Day Range

$1.46 - $1.62

52 Wk Range

1.23 - 3.95

Market Cap

$55.17M

P/E Ratio

Dividend Yield

Exchange

NASDAQ

RSI

Short Interest

7.06%

Days to Cover

12.09

About

Sector

Health Care

Industry

Biotechnology

Metagenomi Therapeutics Inc is an vivo genome editing company capitalizing on its proprietary technologies to create curative genetic medicines for patients. The company leverages machine learning and artificial intelligence to enhance its signature ...

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry